Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › Foundation Medicine, Natera to Develop Liquid Biopsy Monitoring Assays

Foundation Medicine, Natera to Develop Liquid Biopsy Monitoring Assays

Sep 24, 2019
|
staff reporter

This article has been updated with financial and other details from a Natera regulatory filing.

NEW YORK – Foundation Medicine and Natera said today that they will jointly develop and commercialize personalized circulating tumor DNA monitoring assays for biopharmaceutical and clinical customers who order the FoundationOne CDx test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Molecular Diagnostics

  1. Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

  2. Qiagen Receives FDA Emergency Use Authorization for SARS-CoV-2 Respiratory Panel

  3. Bio-Rad Laboratories ddPCR Shows Accuracy Benefits in COVID-19 Detection Studies

  4. Cue Health Awarded $13M BARDA Contract for POC Coronavirus Test

  5. NeuMoDx Gets FDA Emergency Use Authorization for Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.